Shokoohi A - Search Results

1

Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based Experience.

Shokoohi A, Berthelet E, Gill S, Prisman E, Sexsmith G, Tran E, White A, Wiseman SM, Wu J, Ho C. Shokoohi A, et al. Cureus. 2020 Feb 27;12(2):e7122. doi: 10.7759/cureus.7122. Cureus. 2020. PMID: 32257668 Free PMC article.

2

Psychosocial Distress Scores and Needs among Newly Diagnosed Sarcoma Patients: A Provincial Experience.

Srikanthan A, Leung B, Shokoohi A, Smrke A, Bates A, Ho C. Srikanthan A, et al. Among authors: shokoohi a. Sarcoma. 2019 Jul 1;2019:5302639. doi: 10.1155/2019/5302639. eCollection 2019. Sarcoma. 2019. PMID: 31354383 Free PMC article.

3

Comparability of laboratory-developed and commercial PD-L1 assays in non-small cell lung carcinoma.

Naso JR, Wang G, Banyi N, Derakhshan F, Shokoohi A, Ho C, Zhou C, Ionescu DN. Naso JR, et al. Among authors: shokoohi a. Ann Diagn Pathol. 2021 Feb;50:151590. doi: 10.1016/j.anndiagpath.2020.151590. Epub 2020 Aug 14. Ann Diagn Pathol. 2021. PMID: 33157383

4

Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patients.

Leung B, Shokoohi A, Bates A, Ho C. Leung B, et al. Among authors: shokoohi a. J Geriatr Oncol. 2021 May;12(4):612-617. doi: 10.1016/j.jgo.2020.10.001. Epub 2020 Nov 4. J Geriatr Oncol. 2021. PMID: 33158770

5

Readiness of Healthcare Systems to Generate Real-World Evidence: Reliability of CT Radiographic End Points for Evaluation of First-Line Systemic Treatment.

Ho C, Chan B, Cameron D, Shokoohi A, Regier DA, Lim H. Ho C, et al. Among authors: shokoohi a. JCO Oncol Pract. 2021 Dec;17(12):e1923-e1929. doi: 10.1200/OP.20.00810. Epub 2021 Jan 22. JCO Oncol Pract. 2021. PMID: 33493006

6

Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.

Wong SK, Hamm J, Shokoohi A, McGahan CE, Ho C. Wong SK, et al. Among authors: shokoohi a. BMC Cancer. 2021 Mar 2;21(1):215. doi: 10.1186/s12885-021-07923-4. BMC Cancer. 2021. PMID: 33653306 Free PMC article.

7

External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.

Sit D, Koh WX, Shokoohi A, Raycraft T, Vu M, Hamm J, Tran E, Berthelet E, Wu J, Olson R, Hamilton SN. Sit D, et al. Among authors: shokoohi a. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):468-478. doi: 10.1016/j.ijrobp.2021.05.006. Epub 2021 May 15. Int J Radiat Oncol Biol Phys. 2021. PMID: 34004228

8

Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world.

Shokoohi A, Al-Hashami Z, Moore S, Pender A, Wong SK, Wang Y, Leung B, Wu J, Ho C. Shokoohi A, et al. Cancer Med. 2022 Jan;11(1):86-93. doi: 10.1002/cam4.4427. Epub 2021 Nov 16. Cancer Med. 2022. PMID: 34786889 Free PMC article.

9

Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report.

Denault MH, Kuang S, Shokoohi A, Leung B, Liu M, Berthelet E, Laskin J, Sun S, Zhang T, Melosky B, Ho C. Denault MH, et al. Among authors: shokoohi a. JTO Clin Res Rep. 2022 Mar 30;3(5):100316. doi: 10.1016/j.jtocrr.2022.100316. eCollection 2022 May. JTO Clin Res Rep. 2022. PMID: 35498385 Free PMC article.

10

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.

Jones L, Rittberg R, Leung B, Shokoohi A, Pender A, Wong S, Al-Hashami Z, Wang Y, Ho C. Jones L, et al. Among authors: shokoohi a. Curr Oncol. 2022 Nov 15;29(11):8686-8692. doi: 10.3390/curroncol29110685. Curr Oncol. 2022. PMID: 36421338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters